Dooseop Kim
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Diabetes Treatment and Management, Peptidase Inhibition and Analysis, Oxidative Organic Chemistry Reactions, Neuropeptides and Animal Physiology, HIV Research and Treatment
Most-Cited Works
- → (2R)-4-Oxo-4-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin- 7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: A Potent, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes(2004)814 cited
- → Dipeptidyl Peptidase IV Inhibition for the Treatment of Type 2 Diabetes(2005)490 cited
- → Translocation of radical sites by intramolecular 1,5-hydrogen atom transfer(1988)196 cited
- → Potent, orally absorbed glucagon receptor antagonists(1999)169 cited
- → Potent 1,3,4-trisubstituted pyrrolidine CCR5 receptor antagonists: effects of fused heterocycles on antiviral activity and pharmacokinetic properties(2005)148 cited
- → Atom transfer cyclization reactions of hex-5-ynyl iodides: synthetic and mechanistic studies(1989)138 cited
- → Atom-transfer cyclization. A novel isomerization of hex-5-ynyl iodides to iodomethylene cyclopentanes(1986)106 cited
- → Unraveling the chemistry of tunichrome(1991)89 cited
- → Effects of Subtype-Selective and Balanced Angiotensin II Receptor Antagonists in a Porcine Coronary Artery Model of Vascular Restenosis(1996)69 cited
- → Iodine atom transfer addition reactions with alkynes. Part 1: Alkyl iodides(1991)66 cited